Literature DB >> 9008283

Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes.

H Z Bass1, J L Fahey, P Nishanian, R Detels, W Cumberland, M Kemeny, S Plaeger.   

Abstract

Human immunodeficiency virus (HIV) type 1 (HIV-1) induces impairment of immune function reflected in reduced lymphocyte proliferative responses. Many other immune changes are induced by HIV-1, but their relationship to lymphocyte functional defects is not known. The present study was designed to correlate functional defects with other HIV disease parameters. Cryopreserved samples from 118 HIV-1-positive subjects and 40 seronegative individuals were examined. The main findings were that impaired proliferative responses to mitogens correlated with (i) decreased cell surface expression of the interleukin-2 receptor (CD25), (ii) increased expression of HLA-DR antigens on CD4 cells, (iii) reduced CD4 and increased CD8 cell numbers, and (iv) increased levels of serum immune complex dissociated p24 antigen. However, impaired function was not associated with increased serum neopterin, beta2-microglobulin, or soluble interleukin-2 receptor or with CD38 antigen expression on lymphocytes. In summary, proliferative functional impairment correlated with some, but not all, immunological changes associated with HIV-1 infection. Most of the phenotypic markers that correlated with altered function are cell surface molecules with significant roles in lymphocyte proliferation and were associated primarily with CD4 cells, compatible with the view that dysregulation of CD4 cells is responsible for impaired function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008283      PMCID: PMC170477          DOI: 10.1128/cdli.4.1.64-69.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  27 in total

1.  AIDS pathogenesis: a dynamic interaction between HIV and the immune system.

Authors:  F Miedema; M Tersmette; R A van Lier
Journal:  Immunol Today       Date:  1990-08

2.  A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals.

Authors:  P Nishanian; K R Huskins; S Stehn; R Detels; J L Fahey
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

3.  Four-year prospective study of homosexual men: correlation of immunologic abnormalities, clinical status, and serology to human immunodeficiency virus.

Authors:  W el-Sadr; M Marmor; S Zolla-Pazner; R E Stahl; R Lyden; D William; S D'Onofrio; S H Weiss; W C Saxinger
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

4.  Predictors of clinical AIDS in young homosexual men in a high-risk area.

Authors:  R Detels; B R Visscher; J L Fahey; J L Sever; M Gravell; D L Madden; K Schwartz; J P Dudley; P A English; H Powers
Journal:  Int J Epidemiol       Date:  1987-06       Impact factor: 7.196

5.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

6.  Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters.

Authors:  E P Gelmann; O T Preble; R Steis; H C Lane; A H Rook; M Wesley; J Jacob; A Fauci; H Masur; D Longo
Journal:  Am J Med       Date:  1985-05       Impact factor: 4.965

7.  Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection.

Authors:  J V Giorgi; P G Nishanian; I Schmid; L E Hultin; H L Cheng; R Detels
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

8.  Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity.

Authors:  O Martínez-Maza; E Crabb; R T Mitsuyasu; J L Fahey; J V Giorgi
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

9.  Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis.

Authors:  B Hofmann; Y X Wang; W G Cumberland; R Detels; M Bozorgmehri; J L Fahey
Journal:  AIDS       Date:  1990-03       Impact factor: 4.177

10.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.

Authors:  A R Moss; P Bacchetti; D Osmond; W Krampf; R E Chaisson; D Stites; J Wilber; J P Allain; J Carlson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12
View more
  9 in total

1.  Regeneration and tolerance factor: a correlate of human immunodeficiency virus-associated T-cell activation.

Authors:  T S Givens; B K DuChateau; J S Boomer; M P Westerman; A Gilman-Sachs; K D Beaman
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 2.  Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.

Authors:  J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

3.  Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection.

Authors:  M Iwashiro; R J Messer; K E Peterson; I M Stromnes; T Sugie; K J Hasenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

4.  Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines.

Authors:  R Geiben-Lynn; M Kursar; N V Brown; E L Kerr; A D Luster; B D Walker
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.

Authors:  G d'Ettorre; G Forcina; M Andreotti; L Sarmati; L Palmisano; M Andreoni; S Vella; C M Mastroianni; V Vullo
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

6.  Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study.

Authors:  C A Kleeberger; R H Lyles; J B Margolick; C R Rinaldo; J P Phair; J V Giorgi
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

7.  Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.

Authors:  S Resino; M L Abad; J Navarro; J M Bellón; S Sánchez-Ramón; M Angeles Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

8.  Expression of the activation antigen CD69 predicts functionality of in vitro expanded peripheral blood mononuclear cells (PBMC) from healthy donors and HIV-infected patients.

Authors:  S D Nielsen; P Afzelius; A K Ersbøll; J O Nielsen; J E Hansen
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

9.  Preserved immune system in long-term asymptomatic vertically HIV-1 infected children.

Authors:  S Resino; R Correa; J M Bellón; M A Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.